AR211931A1 - Metodo de tratar en forma semicontinua sangre entera para proveer extractos de calonas homopoyeticas - Google Patents

Metodo de tratar en forma semicontinua sangre entera para proveer extractos de calonas homopoyeticas

Info

Publication number
AR211931A1
AR211931A1 AR264235A AR26423576A AR211931A1 AR 211931 A1 AR211931 A1 AR 211931A1 AR 264235 A AR264235 A AR 264235A AR 26423576 A AR26423576 A AR 26423576A AR 211931 A1 AR211931 A1 AR 211931A1
Authority
AR
Argentina
Prior art keywords
homopoyetic
calones
continuously
whole blood
treating whole
Prior art date
Application number
AR264235A
Other languages
English (en)
Spanish (es)
Original Assignee
Union International Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union International Co Ltd filed Critical Union International Co Ltd
Application granted granted Critical
Publication of AR211931A1 publication Critical patent/AR211931A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/18Erythrocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/15Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AR264235A 1975-08-05 1976-07-05 Metodo de tratar en forma semicontinua sangre entera para proveer extractos de calonas homopoyeticas AR211931A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB32659/75A GB1579120A (en) 1975-08-05 1975-08-05 Extracts of the haemopoietic system

Publications (1)

Publication Number Publication Date
AR211931A1 true AR211931A1 (es) 1978-04-14

Family

ID=10342062

Family Applications (1)

Application Number Title Priority Date Filing Date
AR264235A AR211931A1 (es) 1975-08-05 1976-07-05 Metodo de tratar en forma semicontinua sangre entera para proveer extractos de calonas homopoyeticas

Country Status (19)

Country Link
US (1) US4294824A (ja)
JP (1) JPS5218807A (ja)
AR (1) AR211931A1 (ja)
AU (1) AU515950B2 (ja)
BE (1) BE844875A (ja)
CA (1) CA1063019A (ja)
DE (1) DE2635065C2 (ja)
DK (1) DK350876A (ja)
FI (1) FI762178A (ja)
FR (1) FR2320106A1 (ja)
GB (1) GB1579120A (ja)
IE (1) IE44378B1 (ja)
IN (1) IN144537B (ja)
IT (1) IT1062655B (ja)
LU (1) LU75535A1 (ja)
NL (1) NL7608651A (ja)
NZ (1) NZ181653A (ja)
SE (1) SE7608771L (ja)
ZA (1) ZA764643B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU182087B (en) * 1980-01-15 1983-12-28 Mta Kiserleti Orvostudomanyi K Process for preparing an active substance for the selective inhibition of the multiplication of normal cells and of cells in myeloide leukemia
JPS6339609Y2 (ja) * 1980-11-21 1988-10-18
JPS59141520A (ja) * 1983-02-02 1984-08-14 Kyowa Hakko Kogyo Co Ltd Dna合成抑制物質
CA2129436A1 (en) * 1992-12-04 1994-06-05 Satoko Yamada Hematopoietic inhibiting factor containing compositions
US5882328A (en) * 1995-01-13 1999-03-16 Qlt Phototherapeutics, Inc. Method to prevent transplant rejection
AU706857B2 (en) * 1995-12-21 1999-06-24 Genzyme Corporation Method for lysing cells
FR2773818B1 (fr) * 1998-01-21 2000-02-18 Pasteur Merieux Serums Vacc Procede et dispositif de lyse de bacteries
DE69920209T2 (de) 1998-03-26 2005-10-06 Viranative Ab Verfahren zur kontinuierlichen reinigung und konzentrierung von leukozyten aus dem blut
US6364907B1 (en) 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
US6664049B1 (en) * 1999-01-20 2003-12-16 Aventis Pasteur S.A. Method and device for cell lysis
US20040208855A1 (en) * 1999-11-17 2004-10-21 Allison Beth Anne Use of PDT to inhibit intimal hyperplasia
DE102004047262A1 (de) * 2004-09-24 2006-04-06 Ipss International Pharmaceutical Strategies & Solutions Pharmazeutisches Mittel umfassend Blutprodukte und deren Verwendung als Injektions- oder Infusionsmittel zur Prophylaxe und Behandlung von Defekten des Immunsystems beim Menschen
EP1640012A1 (de) * 2004-09-24 2006-03-29 Salama, Zoser B. nat.rer.Dr. Pharmazeutisches Mittel enthaltend Blutbestandteile 10 kDa und deren Verwendung zur Prophylaxe und Behandlung von Defekten des Immunsystems
US20060067942A1 (en) * 2004-09-24 2006-03-30 Salama Zoser B Pharmaceutical agent comprising amino acids, peptides, proteins and/or fractions and fragments thereof and the use of same in the prophylaxis and treatment of immune system deficiency in humans and animals

Also Published As

Publication number Publication date
FR2320106B1 (ja) 1980-11-07
IN144537B (ja) 1978-05-13
NZ181653A (en) 1979-01-11
SE7608771L (sv) 1977-02-06
GB1579120A (en) 1980-11-12
DK350876A (da) 1977-02-06
AU1661476A (en) 1978-02-09
FR2320106A1 (fr) 1977-03-04
IT1062655B (it) 1984-10-20
US4294824A (en) 1981-10-13
LU75535A1 (ja) 1978-02-13
DE2635065A1 (de) 1977-02-17
JPS5218807A (en) 1977-02-12
AU515950B2 (en) 1981-05-14
IE44378B1 (en) 1981-11-04
FI762178A (ja) 1977-02-06
NL7608651A (nl) 1977-02-08
BE844875A (fr) 1977-02-04
CA1063019A (en) 1979-09-25
IE44378L (en) 1977-02-05
DE2635065C2 (de) 1983-10-27
ZA764643B (en) 1978-03-29

Similar Documents

Publication Publication Date Title
PL207037A1 (pl) Sposob wytwarzania mononitrobenzenu
PL201671A1 (pl) Sposob wytwarzania kwasu tereftalowego
AR211931A1 (es) Metodo de tratar en forma semicontinua sangre entera para proveer extractos de calonas homopoyeticas
PL198010A1 (pl) Sposob wytwarzania kwasu tereftalowego
PL215006A1 (pl) Sposob wytwarzania 4-chlorowcodwuhydropiranow
PL193761A1 (pl) Sposob wytwarzania czteropierscieniowych chinonow
GB1553424A (en) Method of treating protozal diseases
PL192020A1 (pl) Sposob wytwarzania n-tetrahydrofurfurylo-noroksymorfonow
PL193861A1 (pl) Sposob wytwarzania alfa-aminoketonow
AR214994A1 (es) Aparato para vaciar acido
PL191156A1 (pl) Sposob wytwarzania nowych epoksyandrostanow
MX150898A (es) Procedimiento mejorado de amoxidacion para la obtencion de nitrilos
PL196436A1 (pl) Sposob natluszczania garbowanej skory
PL203997A1 (pl) Sposob garbowania skor
PL202798A1 (pl) Sposob wytwarzania pochodnych kwasu azyrydynokarboksylowego-1
PL193604A1 (pl) Sposob wytwarzania nowych d-homosteroidow
AR209472A1 (es) Procedimiento para champanificacion de vinos de circulacion continua
PL201817A1 (pl) Sposob wytwarzania mononitrotoluenu
BR7602001A (pt) Brinquedo insuflado desmontavel para auxiliar o processo terapeutico da estimulacao precoce dentro do lar
BG26525A4 (bg) Метод за получаване на n-хорметилфталамид
PL196074A1 (pl) Sposob uzdatniania wody
PL205152A1 (pl) Sposob wapnienia skor
PL190272A1 (pl) Sposob garbowania skor swinskich
PL94527B1 (pl) Sposob modyfikacji poliuretanow
PL203112A1 (pl) Sposob wytwarzania n-acetyloaminoarylo-beta-chlorowinylosulfonow